Dublin-based Mater Private Healthcare has entered into a joint venture with Clatterbridge Cancer Centre NHS Foundation Trust to launch a private cancer clinic in Merseyside.
The facility, named the Clatterbridge Clinic, will offer chemotherapy and radiotherapy treatments for patients in the area, as well as two unique therapies for patients with bowel and eye cancers.
The deal marks Mater’s first foray into the UK healthcare market and the company is reported to be exploring other opportunities in the UK.
Fergus Clancy, Mater chief executive, said: “Moving into the UK market with joint venture arrangements such as this is a strategic priority for our business, which has a long history in Ireland and acknowledged expertise in the care arena.
“We regard the UK market as one with significant opportunities for growth and development over coming years.”
Clatterbridge Cancer Centre Trust chief executive Andrew Cannell added: “Our vision is to provide the best cancer care to the people we serve and we intend to use the profits generated from this development to enhance the NHS services we provide and continue to offer out patients the outstanding level of care and supportive environment we are known for.
“We must be able to compete with existing private patient providers in the region and are delighted to be partners with the Mater Private in this exciting joint venture.”
Mater operates a private catholic hospital in Dublin.